KTTA
Closed
Pasithea Therapeutics Corp
0.7346
+0.0133 (+1.84%)
Last Update: 01 Jul 2025 23:08:00
Yesterday: 0.7213
Day's Range: 0.7131 - 0.74
Send
sign up or login to leave a comment!
When Written:
0.4
Pasithea Therapeutics Corp is a biotechnology company that focuses on developing novel treatments for sleep disorders. The company's lead product candidate, PTX-022, is a non-addictive, non-sedating drug that targets the orexin system in the brain. The drug is being developed for the treatment of narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks.
Pasithea Therapeutics Corp was founded in 2017 and is headquartered in San Diego, California. The company is backed by leading investors in the biotech industry and has a team of experienced scientists and executives with a track record of developing successful drugs. Pasithea Therapeutics Corp is committed to improving the lives of patients with sleep disorders and is dedicated to advancing its pipeline of innovative therapies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Pasithea Therapeutics Corp was founded in 2017 and is headquartered in San Diego, California. The company is backed by leading investors in the biotech industry and has a team of experienced scientists and executives with a track record of developing successful drugs. Pasithea Therapeutics Corp is committed to improving the lives of patients with sleep disorders and is dedicated to advancing its pipeline of innovative therapies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








